Silver Spike Investment Corp. (SSIC)
USD 10.74
(1.27%)
USD 10.74
(1.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3 Million USD | 551.65% |
| 2022 | 461.88 Thousand USD | -3.71% |
| 2021 | 479.69 Thousand USD | 10.03% |
| 2020 | 435.97 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 5.81 Million USD | 93.22% |
| 2023 FY | 3 Million USD | 551.65% |
| 2023 Q4 | 3 Million USD | 69.89% |
| 2023 Q3 | 1.77 Million USD | 38.8% |
| 2023 Q2 | 1.27 Million USD | 11.8% |
| 2023 Q1 | 1.14 Million USD | 147.18% |
| 2022 Q3 | 571.89 Thousand USD | 4.85% |
| 2022 FY | 461.88 Thousand USD | -3.71% |
| 2022 Q4 | 461.88 Thousand USD | -19.24% |
| 2022 Q2 | 545.45 Thousand USD | 13.71% |
| 2022 Q1 | 479.69 Thousand USD | 0.0% |
| 2021 Q2 | 873.6 Thousand USD | 0.0% |
| 2021 FY | 479.69 Thousand USD | 10.03% |
| 2020 FY | 435.97 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 660.79 Million USD | 99.545% |
| Theratechnologies Inc. | 98.63 Million USD | 96.949% |
| Safety Shot Inc | 3.89 Million USD | 22.667% |
| Cosmos Health Inc. | 30.25 Million USD | 90.051% |
| Cronos Group Inc. | 43.73 Million USD | 93.118% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | 99.632% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | 93.787% |
| Organogenesis Holdings Inc. | 181.36 Million USD | 98.34% |
| Universe Pharmaceuticals INC | 13.75 Million USD | 78.117% |
| ProPhase Labs, Inc. | 42.54 Million USD | 92.925% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | 65.626% |
| Dynavax Technologies Corporation | 375.02 Million USD | 99.197% |
| Radius Health, Inc. | 804.29 Million USD | 99.626% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | 67.272% |
| Alvotech | 1.88 Billion USD | 99.84% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | 50.977% |
| Alpha Teknova, Inc. | 38.55 Million USD | 92.193% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | 97.801% |
| SCYNEXIS, Inc. | 55.45 Million USD | 94.572% |
| Harrow Health, Inc. | 241.75 Million USD | 98.755% |
| Biofrontera Inc. | 23.13 Million USD | 86.992% |
| DURECT Corporation | 30.4 Million USD | 90.101% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | 99.383% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | 99.362% |
| OptiNose, Inc. | 194.33 Million USD | 98.451% |
| RedHill Biopharma Ltd. | 20.97 Million USD | 85.653% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | 98.164% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | 94.269% |
| SIGA Technologies, Inc. | 57.97 Million USD | 94.809% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | 98.631% |
| Shineco, Inc. | 47.6 Million USD | 93.677% |
| Phibro Animal Health Corporation | 725.54 Million USD | 99.585% |
| Procaps Group S.A. | 462.06 Million USD | 99.349% |
| TherapeuticsMD, Inc. | 14.02 Million USD | 78.535% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -1271.146% |
| Viatris Inc. | 27.21 Billion USD | 99.989% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | 50.977% |
| Rockwell Medical, Inc. | 30.88 Million USD | 90.254% |
| Incannex Healthcare Limited | 5.83 Million USD | 48.373% |
| Aytu BioPharma, Inc. | 90.37 Million USD | 96.67% |
| Tilray Brands, Inc. | 892.11 Million USD | 99.663% |
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | 99.682% |
| PetIQ, Inc. | 645.22 Million USD | 99.534% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | 99.705% |
| Journey Medical Corporation | 56.49 Million USD | 94.673% |
| Alimera Sciences, Inc. | 107.35 Million USD | 97.196% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | 85.88% |
| Assertio Holdings, Inc. | 148.41 Million USD | 97.972% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -58.749% |
| Embecta Corp. | 2.03 Billion USD | 99.852% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | 64.551% |
| Procaps Group, S.A. | 462.06 Million USD | 99.349% |
| PainReform Ltd. | 2.69 Million USD | -11.848% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | 98.264% |
| Hempacco Co., Inc. | 18.82 Million USD | 84.009% |
| Talphera, Inc. | 6.29 Million USD | 52.149% |
| Pacira BioSciences, Inc. | 704.25 Million USD | 99.573% |
| Alvotech | 1.88 Billion USD | 99.84% |
| Lantheus Holdings, Inc. | 835.25 Million USD | 99.64% |
| Kamada Ltd. | 109.96 Million USD | 97.263% |
| Indivior PLC | 1.95 Billion USD | 99.846% |
| Currenc Group, Inc. | 177.67 Million USD | 98.306% |
| Evoke Pharma, Inc. | 9.64 Million USD | 68.804% |
| Flora Growth Corp. | 17.22 Million USD | 82.523% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | 64.551% |
| Evolus, Inc. | 209.68 Million USD | 98.565% |
| HUTCHMED (China) Limited | 536.38 Million USD | 99.439% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | 99.655% |
| Akanda Corp. | 12.66 Million USD | 76.242% |